Coronavirus Disease 2019 (COVID-19) Vaccines and Drugs Contract Pharmaceutical Development and Manufacturing Relationships

Coronavirus Disease 2019 (COVID-19) Vaccines and Drugs Contract Pharmaceutical Development and Manufacturing Relationships

  • September 2021 •
  • 52 pages •
  • Report ID: 6151839 •
  • Format: PDF
Coronavirus Disease 2019 (COVID-19) Vaccines and Drugs Contract Pharmaceutical Development and Manufacturing Relationships

Summary
This report is the companion to Contract Manufacturing Service Agreements - Rising Manufacturing Opportunities Driven by Pharmaceutical Pipeline Expansion (July 2020).IT covers contract manufacturing agreements for COVID-19 vaccines and drugs worldwide, across a range of different services and manufacturing scales.

It covers clinical and commercial contracts.As COVID-19 pharmaceuticals are being ordered in billions of doses by numerous governments, the number of contract service agreements secured serves as an indicator of a CMO’s performance.

This report is critical for establishing an understanding of the overall CMO industry as it responds to the challenges and opportunities of the pandemic.

Scope
- This 52-page report gives an important expert quantitative analysis of the contract manufacturing industry’s response to the COVID-19 pandemic. Findings are based on the industry’s most comprehensive databases of the CMO industry (Databases of Contract Service Providers, Drugs, and Deals).
- This analysis is primarily driven by the Deals Database, which is continuously updated and reveals manufacturing relationships for Pharma products and the types of services offered.

The 23 figures and 6 tables throughout the report illustrate major points and trends. This report is required reading for -
- CMO executives who must have deep understanding of the COVID-19 vaccine and drug landscape -- both pipeline and marketed -- to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy
- Overview of contract manufacturing agreements worldwide for COVID-19 pharmaceuticals and the levels of outsourcing associated with different services and drug type
- Detailed view of CDMO performance by contract manufacturing agreement and an assessment of their manufacturing scale
- Manufacturing agreements are assessed by different molecule types, service type, dose form, facility geography, sponsor company types, and CDMO types.
Loading...

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.